Zobrazeno 1 - 10
of 2 837
pro vyhledávání: '"Mitchell EP"'
Autor:
Hochster HS; Rutgers Cancer Institute, New Brunswick, NJ, USA., Catalano P; ECOG-ACRIN Biostatistics Center, Boston, MA, USA., Weitz M; ECOG-ACRIN Biostatistics Center, Boston, MA, USA., Mitchell EP; Thomas Jefferson University Hospital, Philadelphia, PA, USA., Cohen D; Mt Sinai Hospital, New York, NY, USA., O'Dwyer PJ; University of Pennsylvania, Philadelphia, PA, USA., Faller BA; Missouri Baptist Medical Center Heartland NCORP, St Louis, MO, USA., Kortmansky JS; Yale Cancer Center, New Haven, CT, USA., O'Hara MH; University of Pennsylvania, Philadelphia, PA, USA., Kricher SM; Northwestern University, Chicago, IL, USA., Lacy J; Yale Cancer Center, New Haven, CT, USA., Lenz HJ; Norris Comprehensive Cancer Center, Los Angeles, CA, USA., Verma U; University of Texas, Southwestern Medical Center, Dallas, TX, USA., Benson AB; Northwestern University, Chicago, IL, USA.
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2024 Sep 01; Vol. 116 (9), pp. 1487-1494.
Autor:
Schneider BP; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN., Zhao F; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA., Ballinger TJ; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN., Garcia SF; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL., Shen F; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN., Virani S; Aurora Cancer Care-Southern Lakes VLCC, Burlington, WI., Cella D; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL., Bales C; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN., Jiang G; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN., Hayes L; Pink-4-Ever Ending Disparities, Indianapolis, IN., Miller N; Pink-4-Ever Ending Disparities, Indianapolis, IN., Srinivasiah J; Georgia NCORP, Decatur, GA., Stringer-Reasor EM; University of Alabama at Birmingham O'Neal Comprehensive Cancer Center, Birmingham, AL., Chitalia A; MedStar Washington Hospital Center, Washington, DC., Davis AA; Washington University School of Medicine, St Louis, MO., Makower DF; Montefiore Medical Center-Weiler Hospital, New York, NY., Incorvati J; Fox Chase Comprehensive Cancer Center, Philadelphia, PA., Simon MA; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL., Mitchell EP; Thomas Jefferson University Hospital, Philadelphia, PA.; Deceased, Baltimore, MD., DeMichele A; University of Pennsylvania, Philadelphia, PA., Miller KD; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN., Sparano JA; Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY., Wagner LI; University of North Carolina, Chapel Hill, NC., Wolff AC; Johns Hopkins University/Sidney Kimmel Comprehensive Cancer Center.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Aug 20; Vol. 42 (24), pp. 2899-2907. Date of Electronic Publication: 2024 Jun 03.
Autor:
Au C; Department of Internal Medicine, Rush University Medical Center, Chicago, IL, USA. Electronic address: cherry_au@rush.edu., Samuelson A; Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA., Perez-Morales J; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA., Schabath MB; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA., Mitchell EP; Department of Medical Oncology, Sidney Kimmel Cancer Center, Philadelphia, PA, USA.
Publikováno v:
Patient education and counseling [Patient Educ Couns] 2024 Dec; Vol. 129, pp. 108395. Date of Electronic Publication: 2024 Aug 21.
Autor:
Stearns V; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins School of Medicine, Baltimore, Maryland., Jegede OA; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, Massachusetts., Chang VT; Veterans Administration New Jersey Health Care System, East Orange, New Jersey.; Rutgers New Jersey Medical School, Newark, New Jersey., Skaar TC; Indiana University School of Medicine, Indianapolis, Indiana., Berenberg JL; University of Hawaii Cancer Center, Honolulu, Hawaii., Nand R; Columbia Saint Mary's Hospital, Milwaukee, Wisconsin., Shafqat A; Heartland Cancer Research NCORP-Missouri Baptist Medical Center, Saint Louis, Missouri., Jacobs NL; Minnesota Oncology Hematology, Minneapolis, Minnesota., Luginbuhl W; Abramson Cancer Center at Chester County Hospital, West Chester, Pennsylvania., Gilman P; Main Line Oncology Hematology Associates, Wynnewood, Pennsylvania., Benson AB 3rd; Northwestern Medicine, Chicago, Illinois., Goodman JR; Saint Joseph Mercy Oakland, Pontiac, Michigan., Buchschacher GL Jr; Kaiser Permanente NCORP, Southern California Kaiser Permanente, Los Angeles, California., Henry NL; University of Michigan Rogel Cancer Center, Ann Arbor, Michigan., Loprinzi CL; Mayo Clinic, Rochester, Minnesota., Flynn PJ; Abbott Northwestern Hospital, Woodbury, Minnesota., Mitchell EP; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania., Fisch MJ; University of Texas MD Anderson Cancer Center, Houston, Texas., Sparano JA; Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, New York., Wagner LI; Wake Forest School of Medicine, Winston Salem, North Carolina.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jul 01; Vol. 30 (13), pp. 2709-2718.
Autor:
Connolly RM; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland.; Cancer Research @UCC, College of Medicine and Health, University College Cork, Ireland., Wang V; Dana Farber Cancer Institute, ECOG-ACRIN Biostatistics Center, Boston, Massachusetts., Hyman DM; Memorial Sloan Kettering Cancer Center, New York, New York., Grivas P; University of Washington, Fred Hutchinson Cancer Center, Seattle, Washington., Mitchell EP; Sidney Kimmel Cancer Center at Thomas Jefferson University Hospital, Philadelphia, Pennsylvania., Wright JJ; Investigational Drug Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Sharon E; Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Gray RJ; Dana Farber Cancer Institute, ECOG-ACRIN Biostatistics Center, Boston, Massachusetts., McShane LM; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Rubinstein LV; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Patton DR; Center for Biomedical Informatics and Information Technology, National Cancer Institute, Bethesda, Maryland., Williams PM; Frederick National Laboratory for Cancer Research, Frederick, Maryland., Hamilton SR; City of Hope National Medical Center, Duarte, California., Wang J; UT Southwestern Simmons Comprehensive Cancer Center, Dallas, Texas., Wisinski KB; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin., Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Conley BA; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Harris LN; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Arteaga CL; UT Southwestern Simmons Comprehensive Cancer Center, Dallas, Texas., O'Dwyer PJ; University of Pennsylvania, Philadelphia, Pennsylvania., Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Flaherty KT; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Apr 01; Vol. 30 (7), pp. 1273-1280.
Autor:
Lawson Y; FACOG, Associate Attending, Baylor University Medical Center, Dallas, TX, United States., Comerford KB; OMNI Nutrition Science, California Dairy Research Foundation, Davis, CA, United States. Electronic address: kbcomerford@cdrf.org., Mitchell EP; Sidney Kimmel Cancer at Jefferson, Philadelphia, PA, United States.
Publikováno v:
Journal of the National Medical Association [J Natl Med Assoc] 2024 Apr; Vol. 116 (2 Pt 2), pp. 219-227. Date of Electronic Publication: 2024 Feb 16.
Autor:
Gong J; Cedars-Sinai Medical Center, Los Angeles, CA., Mita AC; Cedars-Sinai Medical Center, Los Angeles, CA., Wei Z; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA., Cheng HH; University of Washington, Seattle, WA., Mitchell EP; Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, PA., Wright JJ; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Ivy SP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Wang V; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA., Gray RC; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA., McShane LM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Rubinstein LV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Patton DR; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Williams PM; Frederick National Laboratory for Cancer Research, Bethesda, MD., Hamilton SR; City of Hope Comprehensive Cancer Center, Duarte, CA., Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Arteaga CL; UT Southwestern Simmons Comprehensive Cancer Center, Dallas, TX., Harris LN; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., O'Dwyer PJ; University of Pennsylvania, Philadelphia, PA., Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Flaherty KT; Massachusetts General Hospital Cancer Center, Boston, MA.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2024 Apr; Vol. 8, pp. e2300407.
Autor:
Chen MF; Memorial Sloan Kettering Cancer Center, New York, NY., Song Z; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA., Yu HA; Memorial Sloan Kettering Cancer Center, New York, NY., Sequist LV; Massachusetts General Hospital Cancer Center, Boston, MA., Lovly CM; Vanderbilt-Ingram Cancer Center, Nashville, TN., Mitchell EP; Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, PA., Moscow JA; Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Gray RJ; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA., Wang V; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA., McShane LM; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Rubinstein LV; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Patton DR; Center for Biomedical Informatics & Information Technology, National Cancer Institute, Bethesda, MD., Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD., Hamilton SR; City of Hope National Medical Center, Duarte, CA., Umemura Y; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI., Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Arteaga CL; UT Southwestern Simmons Comprehensive Cancer Center, Dallas, TX., Harris LN; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., O'Dwyer PJ; University of Pennsylvania, Philadelphia, PA., Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Flaherty KT; Massachusetts General Hospital Cancer Center, Boston, MA.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2024 Apr; Vol. 8, pp. e2300454.
Autor:
Gong J; Cedars-Sinai Medical Center, Los Angeles, CA., Mita AC; Cedars-Sinai Medical Center, Los Angeles, CA., Wei Z; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA., Cheng HH; University of Washington, Seattle, WA., Mitchell EP; Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, PA., Wright JJ; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Ivy SP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Wang V; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA., Gray RC; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA., McShane LM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Rubinstein LV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Patton DR; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Williams PM; Frederick National Laboratory for Cancer Research, Bethesda, MD., Hamilton SR; City of Hope Comprehensive Cancer Center, Duarte, CA., Alva AS; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI., Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Arteaga CL; UT Southwestern Simmons Comprehensive Cancer Center, Dallas, TX., Harris LN; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., O'Dwyer PJ; University of Pennsylvania, Philadelphia, PA., Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Flaherty KT; Massachusetts General Hospital Cancer Center, Boston, MA.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2024 Apr; Vol. 8, pp. e2300406.
Autor:
Dotan E; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA., Lynch SM; Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA., Ryan JC; Pfizer Oncology, Pfizer Inc., New York, New York, USA., Mitchell EP; Clinical Professor of Medicine and Medical Oncology, Sidney Kimmel Cancer Center at Jefferson, Philadelphia, Pennsylvania, USA.
Publikováno v:
Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (3), pp. e6790. Date of Electronic Publication: 2024 Jan 17.